a-Synuclein oligomers are increasingly considered to be responsible for the death of dopaminergic neurons in Parkinson's disease. The toxicity mechanism of a-synuclein oligomers likely involves membrane permeabilization. Even though it is well established that a-synuclein oligomers bind and permeabilize vesicles composed of negatively-charged lipids, little attention has been given to the interaction of oligomers with bilayers of physiologically relevant lipid compositions. We investigated the interaction of a-synuclein with bilayers composed of lipid mixtures that mimic the composition of plasma and mitochondrial membranes. In the present study, we show that monomeric and oligomeric a-synuclein bind to these membranes. The resulting membrane leakage differs from that observed for simple artificial model bilayers. Although the addition of oligomers to negatively-charged lipid vesicles displays fast content release in a bulk permeabilization assay, adding oligomers to vesicles with compositions mimicking mitochondrial membranes shows a much slower loss of content. Oligomers are unable to induce leakage in the artificial plasma membranes, even after long-term incubation. CD experiments indicate that binding to lipid bilayers initially induces conformational changes in both oligomeric and monomeric a-synuclein, which show little change upon long-term incubation of oligomers with membranes. The results of the present study demonstrate that the mitochondrial model membranes are more vulnerable to permeabilization by oligomers than model plasma membranes reconstituted from brainderived lipids; this preference may imply that increasingly complex membrane components, such as those in the plasma membrane mimic used in the present study, are less vulnerable to damage by oligomers.
Introduction
Parkinson's disease (PD) is one of the most common human neurodegenerative diseases, involving the progressive loss of dopaminergic neurons in the substantia nigra in the midbrain [1] . The appearance of Lewy bodies is characteristic of the pathology of PD. The main component of these Lewy bodies is the protein a-synuclein (aS), which is present as amyloid fibrils. aS comprises a 140 amino acid intrinsically disordered protein [2] [3] [4] [5] [6] [7] of as yet unknown function. In PD, aggregation of aS causes the protein to lose its putative function and gain toxicity [8] [9] [10] [11] . aS consists of a positively-charged N-terminal region (residues containing imperfect KTKEGV repeats, a hydrophobic NAC region (residues 61-95) and a negativelycharged C-terminal region (residues 96-140). For membrane binding, the N-terminal part of aS plays a key role. Upon binding to phospholipid membranes, the protein adopts an a-helical structure [12, 13] . Interactions of monomeric aS with lipid vesicles of different compositions and size have been reported [14] [15] [16] [17] [18] [19] . Current consensus suggests that intermediate species in the fibril formation pathway of aS are the toxic species involved in cell death in PD [10, [20] [21] [22] . Despite structural differences between aS oligomers and monomers, they both show high affinity for negatively-charged membranes. We have previously shown that oligomer binding induces leakage of artificial negatively-charged lipid vesicles. Although several studies [23] [24] [25] have shown that isolated oligomers can decrease the integrity of simple negatively-charged lipid vesicles, little is known about how these species bind and permeabilize natural membranes. Mitochondrial damage has been observed in PD and mitochondrial membranes are therefore considered to be a likely target for oligomer-induced damage [26] [27] [28] . Mitochondrial membranes are enriched in cardiolipin [29] , a unique negatively-charged diphosphatidylglycerol lipid. Monomeric aS shows a high binding affinity to cardiolipin-containing membranes [30, 31] . Quantitative correlation between aS in mitochondria and cytosol confirmed that monomeric aS interacts with mitochondrial membranes [32] . Moreover, it has been reported that aS is present on mitochondrial membranes in functional dopaminergic neurons of the substantia nigra [33, 34] , where, at physiological concentrations, aS is mainly localized at the mitochondrial inner membrane and only a small fraction is found at the outer membrane [32, 35] . However, a contrasting report suggests that aS is localized in the outer mitochondrial membrane [27] . Mitochondria of dopaminergic neurons in brains of PD patients contain a higher concentration of aS than normal brains [36] . A recent study has suggested that wild-type aS is mainly localized in mitochondria-associated endoplasmic reticulum membranes and modulates the morphology of mitochondria [37] . Besides these membranes, the plasma membrane has been indicated as a site of oligomer-induced damage. Upon internalization, aS colocalizes with the inner leaflet of the plasma membrane [38, 39] . In a yeast model, it was found that aS binds to plasma membranes [40] . Finally, a recent report suggests that aS can interact with lipids in the plasma membrane, increasing the membrane permeability as a potential mechanism of extracellular neurotoxicity [41] .
In the present study, we investigate the binding of specific, well-characterized, oligomeric aS species to lipid membranes made of physiologically relevant mitochondrial and plasma membrane lipid mixtures. We show that these oligomers cause slow permeabilization of mitochondrial inner membrane mimics, whereas they bind to (but could not induce leakage in) plasma membrane inner leaflet model systems.
Results
Binding of aS monomers to bilayers that mimic the lipid composition of natural membranes Electrostatic interactions play a key role in binding of monomers to negatively-charged membranes. Membrane binding of monomers is mainly associated with positive charges on the N-terminal part of the protein [19] . Upon binding to negatively-charged lipid bilayers, monomers adopt an amphipathic a-helical structure. Fluorescently labeled monomers colocalize with the control 1,2-dioleoylphosphatidylglycerol (DOPG) vesicles (Fig. 1A) and with giant unilamellar vesicles (GUVs) composed of both the mitochondrial and plasma membrane mimicking lipid mixtures (Fig. 1B,C) . Analysis of the Alexa 488-fluorescence intensity at GUV membranes showed that the highest amount of monomers was bound at DOPG membranes (Fig. 1D) . Unexpectedly, not all brain phosphatidylethanolamine (PS) : brain phosphatidylethanolamine (PE) : cholesterol vesicles bound monomers, with approximately 50% of the vesicles not showing any colocalization of labeled monomers and GUVs. It should be noted that only vesicles that bind aS were taken into account in in Fig. 1D .
CD spectroscopy was used to assess whether binding of monomers to vesicles of all lipid compositions resulted in conformational changes in the protein.
Monomers in solution showed CD spectra typical for an intrinsically disordered protein with a negative peak at 198 nm. As previously reported, aS monomers form an a-helix upon binding to small unilamellar vesicles (SUVs) [13, 42] . Upon binding membranes mimicking plasma or mitochondrial lipid compositions, monomers adopt an a-helical structure that is characterized by two negative bands at 208 and 222 nm in the CD spectrum. The a-helical content of the protein upon binding was estimated from the mean residue ellipticity (MRE) at 222 nm as explained in the Materials and methods. Binding of monomers to control DOPG vesicles resulted in an a-helical content of 65.1 AE 1.2%. Monomers binding to cardiolipin (CL) : 1-palmitoyl-2-oleoylphosphatidylethanolamine (POPE) : 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) membranes or membranes composed of brain PS : brain PE : cholesterol adopted a comparable amount of a-helix (59.0 AE 0.4% and 61.1 AE 0.3%, respectively) (Fig. 2) . The similarity of the CD spectra suggests that aS monomers were fully bound and in a predominantly a-helical conformation at saturating lipid concentrations for all types of natural membranes tested. There were no changes in a-helical content of aS monomers bound to brain PS : brain PE : cholesterol vesicles when comparing CD spectra immediately after binding or after 20 h of incubation ( Fig. 2A) . CD data points below 205 nm were not taken into account because of the high noise, likely as a result of the presence of some other organic compounds in the lipid mixtures of brain lipids.
Do aS oligomers bind to bilayers mimicking the lipid composition of natural membranes and does this binding result in conformational changes?
We have previously shown that aS oligomers can bind to lipid membranes composed of negatively-charged lipids such as DOPG or POPG [43] . The binding of fluorescently labeled oligomers to GUVs with a lipid composition mimicking either negatively-charged, neuronal or mitochondrial membranes was studied using confocal microscopy. We observed that oligomers bind to bilayers mimicking the lipid composition of both the mitochondrial inner membrane and the plasma membrane inner leaflet (Fig. 3B,C) . A semi-quantitative comparison of oligomer membrane binding was carried out in accordance with that used for the monomers. Oligomers showed comparable binding to DOPG, CL : POPE : POPC and brain PS : brain PE : cholesterol GUVs (Fig. 3D) . Similar to the results observed for monomer binding, we also observed that not all brain PS : brain PE : cholesterol membranes bound oligomers.
We further investigated whether the membrane binding caused conformational changes in the oligomers similar to those observed for monomeric aS using CD spectroscopy. In solution, oligomers showed some bsheet conformation (Fig. 4) . Binding of oligomers to vesicles resulted in a small change in protein conformation for both lipid mixtures. Oligomers showed an increase in a-helical content upon the addition of SUVs. The a-helical content of the oligomers was comparable for all lipid membranes studied and did not change over time. Oligomers bound to brain PS : brain PE : cholesterol membranes showed similar CD spectra immediately after the addition of protein to membranes and after 20 h of incubation (Fig. 4) .
We further investigated the membrane disrupting properties of oligomers by studying the kinetics of membrane permeabilization using a dye release assay. 
Kinetics of membrane permeabilization (dye release assay)
Oligomers have been shown to disrupt membranes composed of negatively-charged lipid vesicles [23] . After the addition of oligomers to a solution of calcein-filled DOPG large unilamellar vesicles (LUVs), a rapid release of encapsulated dye was observed (Fig. 5A) . We have previously shown that monomers and fibrils could also cause membrane permeabilization of negatively-charged PG vesicles, although much higher concentrations of the protein are necessary to achieve comparable leakage [23] . A comparison of the oligomer-induced leakage kinetics of the dye from DOPG LUVs with dye encapsulated in vesicles of lipid bilayers that mimic physiologically relevant membrane compositions revealed large differences. Although oligomer binding was observed after 30 min of incubation, very little oligomer-induced vesicle leakage of membranes that mimic natural membranes was observed at these time scales. For LUVs composed of a mixture of CL : POPE : POPC, a slow dye leakage was observed, which was still increasing after 18 h (Fig. 5B ). For these LUVs, the oligomer-induced leakage was concentration-dependent; higher oligomer concentrations showed more leakage. By contrast, even after 18 h of incubation, oligomer concentrations as high as 4 lM did not result in more than 2% membrane leakage for bilayers composed of brain PS:brain PE:cholesterol (Fig. 5C ). To obtain a better understanding of the observed slow release kinetics, we used the diffusion equation assuming steady-state release to fit the data. In the absence of oligomers the change in concentration, c, of dye in the vesicles was assumed to follow the expression c = c(0)[1 À e(
Àkt )] where the rate constant is k = P c 9 A/V, V is the volume of the vesicle, P c is the membrane permeability for calcein and A is the area over which diffusion takes place. To fit the data in presence of oligomers, we expect the rate constant to change or more exponents to be required to better describe the dye release kinetics. When oligomers were added, fast leakage was observed for DOPG LUVs. This is not the case for membranes composed of CL : POPE : POPC. Oligomer-induced leakage from these vesicles required a fit with at least three exponentials. One of these exponents is comparable for all oligomer concentrations (the exponent associated with amplitude C in Table 1 ). This amplitude (C) decreases with increasing oligomer concentration and was attributed to the calcein permeability of the bare bilayer. With increasing oligomer concentration, a decreasing fraction of vesicles is not affected by oligomers and shows leakage comparable to bare membranes. From the slow exponent attributed to the bare membrane, the calcein permeability P c of the CL : POPE : POPC membrane was calculated to be approximately 10 À13 cmÁs À1 . The amplitudes of the other two exponents increase with increasing oligomer concentration, indicating that these contributions result from the presence of oligomers. Both oligomer-related rate constants were observed to increase with increasing oligomer concentration (Table 1) .
Discussion
It is well established that binding of aS to lipid bilayers is accompanied by an increase in a-helical content [13] . The binding of aS to lipid bilayers strongly depends on the presence of negatively-charged lipids [ 13, 14, 19, [44] [45] [46] . However, although most studies suggest that neutral membranes do not bind aS [13, 47] , other studies claim differently [14, 48] . The amount of aS bound to lipid bilayers is proportional to the number of available binding sites and therefore to the fraction of negatively-charged lipids in the bilayer [14, 19] . Earlier studies with brain-derived lipids showed no binding of aS to lipid bilayers that contained only 10-15% of PS lipids, indicating that the 20% used in the present study is close to the minimal amount required for aS binding [13] . Variations in composition of the brain PS : brain PE : cholesterol GUVs may explain why monomers did not bind to all brain PS : brain PE : cholesterol GUVs. This variation in composition is possibly caused by the presence of brain PS in the lipid mixture. It has been suggested that brain PS can interfere with the electroformation of GUVs resulting in variation in lipid composition of the resulting vesicles [49] .
In the presence of excess vesicles of all lipid compositions (DOPG or natural lipids), aS showed comparable results in CD binding studies. The maximal a-helical content of the protein did not depend on the negatively-charged lipid species. Interactions of CL containing vesicles with aS monomers have been characterized by 19 F-NMR [31] . It was proposed that the positively-charged N-terminal region is involved in binding via an interaction between positivelycharged lysines and negatively-charged CL [31] . The protein binds to lipid surfaces through an amphipathic a-helix adopted by 100 amino acid residues on the N-terminal part of the protein, whereas the acidic C-terminal tail of the protein remains in solution [2] . According to the literature, aS monomers adopt 41% a-helix in the presence of 1 mM SDS [50] , whereas, upon binding to DPPC : DPPG vesicles, 61% of the protein adopted the a-helical conformation [51] , which is comparable to the observations reported in the present study.
Similar to aS monomers, oligomers were found to bind lipid bilayers of all compositions studied. However, compared to observations on aS monomers, the helical content observed in the presence of oligomers was much lower [23] . It is possible that only the monomers in the oligomer facing the bilayer bind the membrane and adopt an a-helical conformation. Alternatively, the interactions between aS monomers in the oligomer may be too strong to permit further conformational changes upon lipid binding.
Oligomers interacting with simple negativelycharged lipid bilayers composed of, for example, DOPG or POPG immediately permeabilize these lipid membranes [25] . Fast content release was also observed for vesicles containing POPC : DOPA lipids [23, 43] . The binding of oligomers to lipid bilayers has been reported to not always result in membrane permeabilization [23, 25] . Even 30 min after the addition of the oligomers, POPG : POPC bilayers remained intact [43, 52] . For the two-component lipid mixture CL : POPC (1 : 3), a lipid composition that comes close to that of mitochondrial membranes, no leakage was observed over short time scales [23] . In the present study, we show that the interaction of oligomers with bilayers does not necessarily result in a fast loss of membrane integrity. Membranes with a lipid composition [CL : POPE : POPC (4 : 3 : 5)] similar to that reported earlier [23] show some dye release over 18 h (Fig. 5B) . However, even over these long time scales, oligomer binding did not result in permeabilization of the plasma membrane mimicking lipid bilayers (brain PS : brain PE : cholesterol) (Fig. 5C) . To describe the oligomer-induced calcein release kinetics from CL : POPE : POPC vesicles, at least three exponentials, and therefore at least three rate constants, were necessary. The presence of more than one rate constant suggests that subpopulations of vesicles are differently affected by the addition of oligomers. The value of one of the rate constants (k 3 in Table 1 ) describing the calcein flux as a function of oligomer concentration is comparable to that observed for lipid bilayers in the absence of oligomers [53, 54] . This suggests that a fraction of the vesicles is not affected by the oligomers. Oligomers either did not bind or did not affect the calcein permeability of this fraction. As expected, the fraction of unaffected vesicles becomes smaller with an increasing oligomer concentration. The amplitude of the other two exponents increases with the oligomer concentration. The dye release kinetics described by these two exponents is therefore attributed to the presence of oligomers in or on the lipid bilayer. Unexpectedly, both rate constants are observed to increase with increasing oligomer concentrations ( Table 1 ). The oligomer-dependent exponents are expected to contain contributions of both the lipid bilayer and the oligomers. Because the leakage is much faster in the presence of oligomers, we assume that the contribution of oligomers is very large compared to the contribution of the bare bilayer. As indicated in the Results, the value of k depends not only on the permeability coefficient P, but also on the volume of the vesicle and the area over which diffusion takes place. With increasing oligomer concentrations, the area covered by oligomers is expected to become larger. In contrast to our observation, this increase in oligomer area should give rise to an increase in the rate constants contributed to oligomers. The observed decrease in the rate constants may result from an increase in vesicle volume (i.e. by incorporation of oligomers in the lipid bilayer). Dynamic light scattering experiments indicate that CL : POPE : POPC LUVs indeed become larger upon incubation with oligomers, supporting the hypothesis that the decrease in rate constants corresponding to oligomer-induced leakage results from a volume increase. The observed change in the CL : POPE : POPC vesicle diameter of approximately 30 nm corresponds to the expected volume change resulting from oligomer incorporation (Fig. 6) . The decrease in leakage observed for brain PS : brain PE : cholesterol bilayers in the presence of oligomers possibly results from the binding of oligomers and blocking of the membrane surface. The permeability of the oligomer-covered surface is low compared to the permeability of the bare membrane surface.
Recent data on more physiologically relevant brain total lipid extract membranes (BTLEMs) have shown that aS causes bilayer defects [55] . We speculate that the brain PS : brain PE : cholesterol model system that we use may show a lipid rearrangement similar to that proposed for BTLEMs. Cholesterol in complex model brain PS : brain PE : cholesterol membranes can have an additional stabilizing effect on these membranes [23, 43, 48, 56] , making them less vulnerable to oligomer-induced leakage. In our experimental system, the inclusion of cholesterol at a constant charge density does not appear to have any appreciable effect on the extent of permeabilization (Fig. 7) . However, it has been suggested that the amount of cholesterol in the plasma membrane is important for the formation of amyloid channels [57, 58] . For the amyloid-forming protein islet amyloid polypeptide, slow dye release from POPG : POPC vesicles was concluded to be caused by the formation of fibrils [59] . The experiments reported in the present study were performed with stable oligomers [60] . Thus, we do not expect that conformational changes and further aggregation play a role in long-term leakage kinetics. Alternatively, any conformational changes in the oligomer may be beyond our detection limit because they involve only a few proteins.
The reported membrane leakage data suggest that complex lipid membranes are less prone to oligomerinduced damage. The complexity of model plasma membranes lies in the composition of the membranes itself, which consist largely of combinations of long and polyunsaturated lipids in the brain lipid extracts used. The results of the present study show that mitochondrial model membranes are more prone to oligomer-induced damage over longer time scales, whereas the more complex plasma membrane model systems do not show a concentration-dependent permeabilization over the same time scale. Other in vitro studies have suggested that the mitochondria specific lipid CL is essential for aS mitochondrial membrane interactions [46] . A recent study [61] confirmed a common mechanism of damage for mitochondrial membranes by amyloid-induced species via direct interactions of these species with membrane phospholipids. Their proposed mechanism agrees very well with our data on mitochondrial model membranes, which is mediated by the increased affinity of these species for CL.
Materials and methods

Expression and purification of aS
Expression and purification of human wild-type aS and the cysteine (Cys) mutant aS-A140C, where alanine at position 140 was replaced with a cysteine, was carried out as described previously [62] . The protein concentration was determined by measuring the absorbance on a spectrophotometer at 276 nm, using molar extinction coefficients of 5600 M À1 Ácm À1 for wild-type and 5745 M À1 Ácm À1 for A140C [60, 63] . The protein was stored at À80°C until further use.
Labeling of aS
The Cys mutant aS-A140C was used for labeling the protein with an Alexa Fluor 488 C5 maleimide dye (A488) (Invitrogen, Carlsbad, CA, USA). Prior to labeling, a six-fold molar excess of dithiothreitol was added to aS-A140C to reduce disulfide bonds. After 30 min of incubation, dithiothreitol was removed using Zeba Spin desalting columns (Pierce, Rockford, IL, USA) and a two-fold excess of A488 was added. After 1 h of incubation, excess of free dye was removed using two desalting steps. The labeling efficiency was estimated to be in the range 90-100% from absorption spectra. To determine the protein and A488 concentration the absorbance at 276 nm was measured using a molar extinction coefficient of 5745 M À1 Ácm À1 for the protein and at 495 nm using a molar extinction coefficient of 72 000 M
À1
Ácm À1 for the dye.
Preparation of unlabeled and labeled aS oligomers
Briefly, oligomers were obtained by incubating aS at high concentrations in the absence of additional factors [23] . Alexa 488 labeled oligomers with 7.5% labeling density, achieved by mixing appropriate quantities of labeled protein (aS-A140C) with unlabeled protein (wild-type), were prepared for membrane binding studies by confocal microscopy. Oligomers were purified and separated from monomers using size-exclusion chromatography on a Superdex TM 200 10/300 GL column (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). Separation of oligomers from monomers is based on size, where larger particles (oligomers) elute first. To confirm the presence of oligomers, a native PAGE gradient gel was used [23] with a polyacrylamide gradient of between 3% and 16%. We have previously demonstrated that oligomers prepared in this manner are composed of approximately 30 monomers, and are stable [60] . Monomers could not be detected in the oligomer preparation (data not shown). Oligomer-induced leakage was < 5%, which is comparable to the data observed with our plasma inner leaflet membrane mimics.
LUV preparation and calcein release assay
All lipids were purchased from Avanti Polar Lipids (Alabaster, AL, USA). In the experiments the lipids used were: POPC, DOPG, POPE, 1 0 ,3 0 -bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol (18 : 1 CL), porcine brain L-a-phosphatidylserine (brain PS), porcine brain L-a-phosphatidylethanolamine (brain PE) and cholesterol.
To mimic the lipid composition of neuronal plasma membranes, we used mixtures of brain PS : brain PE : cholesterol in a molar ratio of 2 : 5 : 3, which corresponds to 20% of negatively-charged lipids. However, no elaborate data of brain lipid compositions are available. The neuronal membrane has approximately 10% negatively-charged lipids, mainly PS, whereas the main components of these membranes are neutral PC and PE phospholipids [64] . However, this estimation of the lipid composition does not take into account asymmetry between the inner and outer leaflets of the membrane [13] . Because aS is an intracellular protein, we chose to the mimic the inner leaflet of the plasma membrane, which is enriched in PS. aS has also been implicated in interactions with mitochondrial membranes. Data from the literature suggest that aS preferentially binds to the mitochondrial inner membrane [29] . To mimic the mitochondrial inner membrane, we used a lipid composition that contains CL : POPE : POPC in a molar ratio 4 : 3 : 5 [29] .
Specific lipid compositions were prepared by mixing 650 lM of lipids in chloroform. The solvent was removed by drying under nitrogen flow. The resulting lipid films were then hydrated for 1 h using 50 mM calcein, 10 mM Hepes and 60 mM NaCl to obtain an osmolality (Cryoscopic osmometer; Gonotec, Berlin, Germany) of 320 mOsmÁkg À1 . The sample was then subjected to five freeze-thaw cycles using liquid nitrogen and a water bath. The temperature of the water bath was kept above the transition temperature of the lipid mixture. The solution was subsequently extruded 11 times through 100-nm pore size filters (Whatman, Maidstone, UK) and finally unencapsulated calcein was removed using PD-10 columns filled with Sephadex G-100 (GE Healthcare Bio-Sciences AB). Long-term calcein release kinetics of the model membranes was followed on a Varian Cary Eclipse fluorometer (Varian Inc., Palo Alto, CA, USA). We used lipid concentrations of 40 lM. The emission intensity was recorded at 515 nm for excitation at 495 nm. Triton X (0.5%) was added to completely lyse the vesicles. All the data points were normalized using the intensity after Triton X treatment as 100% leakage.
Semi-quantitative aS monomer and oligomer binding assay
GUVs were prepared in sucrose solution as described previously by Angelova and Dimitrov [65] . The sucrose concentration was equiosmolar to the 10 mM Hepes, 150 mM NaCl solution in which the proteins were dissolved. 1% DOPE-rhodamine was included in the lipid mixtures to facilitate visualization of the lipid membrane.
GUVs mimicking natural lipid compositions were equilibrated with fluorescently labeled oligomers for 30 min before imaging. DOPG vesicles were used as a positive control for binding of monomers and oligomers to membranes.
The experiments were performed using the same experimental settings (master gain, digital offset and laser power) for imaging the binding of both monomers (Fig. 1) and oligomers (Fig. 3) . DOPE-rhodamine was excited with a He/Ne laser (543 nm) and Alexa 488 was excited with an Argon laser (488 nm) on a CLSM 510 confocal microscope (Carl Zeiss, Oberkochen, Germany). We used the script plot profile in IMAGEJ (NIH, Bethesda, MD, USA) to extract semi-quantitative fluorescence values reporting on the binding of monomers and oligomers to membranes. The amount of aS bound to GUV membranes was estimated from the peak values of the Alexa 488 intensity profiles and averaged for at least 15 vesicles on five random cross-sections using the same imaging settings (master gain, digital offset and laser power). Figures 1A-C and 3A-C show representative confocal images of the binding of fluorescently labeled aS monomers (Fig. 1) and oligomers (Fig. 3) .
SUVs preparation and binding of aS oligomers to SUVs
Lipid mixtures that contain 3.8 mM of lipids in chloroform were prepared. After removing traces of chloroform, a thin lipid film was dissolved in 10 mM K-phosphate buffer. SUVs were prepared from this solution by sonicating for 30 min using a tip sonicator (Labsonic, Branson Ultrasonics, Danbury, CT, USA) at maximum amplitude on ice. Binding-induced conformational changes of oligomeric and monomeric aS were investigated using CD spectroscopy [66] . Both protein and lipids samples were prepared in 10 mM K-phosphate buffer. Spectra were recorded using a Jasco 715 spectropolarimeter (Jasco Inc., Easton, MD, USA) in the range 190-260 nm with a step size of 0.2 nm, band width 2 nm and scanning speed 50 nmÁmin À1 in 1-mm quartz cuvettes. The spectra represent the mean of three scans and were corrected for the background from K-phosphate buffer and aS-free vesicles. Monomer and oligomer concentrations were 16 and 10 lM of equivalent monomer concentration, respectively, keeping the lipid to protein ratio 260 : 1 for oligomers binding to SUVs and 170 : 1 for monomers binding to SUVs. A lipid concentration of 2.72 mM resulted in the above-mentioned lipid to protein ratio. These ratios were chosen to obtain complete binding of the protein [13, 42] . MREs (degÁdmol À1 Ácm À2 )
were calculated using Eqn (1), where c is the protein concentration, l is the pathlength cuvette and n residues is the number of residues (amino acids):
MRE ¼ recorded value À buffer value lðcmÞ Â n residues Â 10 Â cðMÞ ð1Þ
In principle, the MRE at any wavelength is a combination of a-helical structure, b-sheet and random coil content of the sample [67] . The a-helical content was estimated by measuring the CD signal at 222 nm; at this wavelength, the contribution of random coil structure is relatively small [68] .
At 222 nm, the a-helical content was obtained using Eqns (2, 3, 4) :
where h helix and h coil could be calculated:
where Θ 222 is the measured mean residue ellipticity at 222 nm, h helix and h coil are mean residue ellipticities at 222 nm of idealized a-helix and random coil proteins, n = 140 amino acids and ϑ is the temperature (°C).
